The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Inactivation of the p34 cdc2 -Cyclin B Complex by the Human WEE1 Tyrosine Kinase
Abstract
Entry into mitosis in Schizosaccharomyces pombe is negatively regulated by the wee1 + gene, which encodes a protein kinase with serine-, theonine-, and tyrosine-phosphorylating activities. The wee1 + kinase negatively regulates mitosis by phosphorylating p34 cdc2 on tyrosine 15, thereby inactivating the p34 cdc2 -cyclin B complex. The human homolog of the wee1 + gene ( WEE1Hu ) was overproduced in bacteria and assayed in an in vitro system. Unlike its fission yeast homolog, the product of the WEE1Hu gene encoded a tyrosine-specific protein kinase. The human WEE1 kinase phosphorylated the p34 cdc2 -cyclin B complex on tyrosine 15 but not on threonine 14 in vitro and inactivated the p34 cdc2 -cyclin B kinase. This inhibition was reversed by the human Cdc25C protein, which catalyzed the dephosphorylation of p34 cdc2 . These results indicate that the product of the WEE1Hu gene directly regulates the p34 cdc2 -cyclin B complex in human cells and that a kinase other than that encoded by WEE1Hu phosphorylates p34 cdc2 on threonine 14.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,831
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2
Gautier, J., Solomon, M. J., Booher, R. N., Bazan, J. F., & Kirschner, M. W. (1991) · Cell · doi:10.1016/0092-8674(91)90583-k · Cited by 841
Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast
Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 833
Xiong, Y., Connolly, T., Futcher, B., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90100-d · Cited by 685
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., & Roberts, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90044-y · Cited by 642
Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein
Strausfeld, U., Labbé, J. C., Fesquet, D., Cavadore, J. C., Picard, A., Sadhu, K., Russell, P., & Dorée, M. (1991) · Nature · doi:10.1038/351242a0 · Cited by 578
Galaktionov, K., & Beach, D. (1991) · Cell · doi:10.1016/0092-8674(91)90294-9 · Cited by 505
The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system
Kumagai, A., & Dunphy, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90315-p · Cited by 503
Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates.
Norbury, C., Blow, J., & Nurse, P. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04896.x · Cited by 491
Cited by
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2
Gyuris, J. (1993) · Cell · doi:10.1016/0092-8674(93)90498-f · Cited by 1,522
Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo
Matsuo, T., Yamaguchi, S., Mitsui, S., Emi, A., Shimoda, F., & Okamura, H. (2003) · Science · doi:10.1126/science.1086271 · Cited by 1,131
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
Puente, B. N., Kimura, W., Muralidhar, S. A., Moon, J., Amatruda, J. F., Phelps, K. L., Grinsfelder, D., Rothermel, B. A., Chen, R., Garcia, J. A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.032 · Cited by 909
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Mueller, P. R., Coleman, T. R., Kumagai, A., & Dunphy, W. G. (1995) · Science · doi:10.1126/science.270.5233.86 · Cited by 695
Hoffmann, I., Clarke, P. R., Marcote, M. J., Karsenti, E., & Draetta, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05631.x · Cited by 684
Schafer, K. A. (1998) · Veterinary Pathology · doi:10.1177/030098589803500601 · Cited by 604
Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., & Piwnica-Worms, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5600 · Cited by 544
Self-citationHirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0463 · Cited by 540
Hoffmann, I., Draetta, G., & Karsenti, E. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06750.x · Cited by 494
Unravelling the biology of SCLC: implications for therapy
Sabari, J. K., Lok, B. H., Laird, J. H., Poirier, J. T., & Rudin, C. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.71 · Cited by 490
DNA damage checkpoint control in cells exposed to ionizing radiation
Iliakis, G., Wang, Y., Guan, J., & Wang, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206682 · Cited by 476
Mertens-Talcott, S. U., Chintharlapalli, S., Li, X., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2416 · Cited by 470
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Cdc25A is a novel phosphatase functioning early in the cell cycle.
Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., & Okayama, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06417.x · Cited by 452
Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle.
Watanabe, N., Broome, M., & Hunter, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07180.x · Cited by 450
Cyclins and cyclin-dependent kinases: take your partners
Pines, J. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90185-p · Cited by 430
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
Lu, X., Nannenga, B., & Donehower, L. A. (2005) · Genes & Development · doi:10.1101/gad.1291305 · Cited by 389
Liu, F., Stanton, J. J., Wu, Z., & Piwnica-Worms, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.571 · Cited by 376
Self-citationCell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
Visconti, R., Della Monica, R., & Grieco, D. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0433-9 · Cited by 366
Checking out the G2/M transition
Smits, V. A. J., & Medema, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00204-4 · Cited by 355
Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
Peyressatre, M., Prével, C., Pellerano, M., & Morris, M. (2015) · Cancers · doi:10.3390/cancers7010179 · Cited by 344
Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control
Lew, D. J., & Kornbluth, S. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80080-9 · Cited by 337
Nakajima, H., Toyoshima-Morimoto, F., Taniguchi, E., & Nishida, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300126200 · Cited by 337
Palmer, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5037 · Cited by 329
CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15.
Solomon, M. J., Harper, J. W., & Shuttleworth, J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05982.x · Cited by 326
Cell cycle regulation of a Xenopus Wee1-like kinase.
Mueller, P. R., Coleman, T. R., & Dunphy, W. G. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.1.119 · Cited by 325
Chhabra, R., Dubey, R., & Saini, N. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-232 · Cited by 324
Sorensen, C. S., & Syljuasen, R. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr697 · Cited by 318
Extensive Crosstalk Between O-GlcNAcylation and Phosphorylation Regulates Cytokinesis
Wang, Z., Udeshi, N. D., Slawson, C., Compton, P. D., Sakabe, K., Cheung, W. D., Shabanowitz, J., Hunt, D. F., & Hart, G. W. (2010) · Science Signaling · doi:10.1126/scisignal.2000526 · Cited by 317
Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity
Booher, R. N., Holman, P. S., & Fattaey, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22300 · Cited by 313
14-3-3 proteins in cell cycle regulation
Hermeking, H., & Benzinger, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.002 · Cited by 309
Beck, H., Nähse-Kumpf, V., Larsen, M. S. Y., O'Hanlon, K. A., Patzke, S., Holmberg, C., Mejlvang, J., Groth, A., Nielsen, O., Syljuåsen, R. G., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00412-12 · Cited by 306
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase
Blasina, A., de Weyer, I. V., Laus, M. C., Luyten, W. H. M. L., Parker, A. E., & McGowan, C. H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80041-4 · Cited by 303
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
Pfister, S. X., Markkanen, E., Jiang, Y., Sarkar, S., Woodcock, M., Orlando, G., Mavrommati, I., Pai, C.-C., Zalmas, L.-P., Drobnitzky, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.015 · Cited by 300
Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.
Izumi, T., & Maller, J. L. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1337 · Cited by 298
The molecular basis for cell cycle delays following ionizing radiation: a review
Maity, A., McKenna, W. G., & Muschel, R. J. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90408-1 · Cited by 294
Mir, S. E., De Witt Hamer, P. C., Krawczyk, P. M., Balaj, L., Claes, A., Niers, J. M., Van Tilborg, A. A. G., Zwinderman, A. H., Geerts, D., Kaspers, G. J. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.011 · Cited by 294
Cell cycle regulation of human WEE1.
McGowan, C. H., & Russell, P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07210.x · Cited by 293
Positive Regulation of Wee1 by Chk1 and 14-3-3 Proteins
Lee, J., Kumagai, A., & Dunphy, W. G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.3.551 · Cited by 291
Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2
Chen, S., Bohrer, L. R., Rai, A. N., Pan, Y., Gan, L., Zhou, X., Bagchi, A., Simon, J. A., & Huang, H. (2010) · Nature Cell Biology · doi:10.1038/ncb2116 · Cited by 281
Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site
Dalal, S. N., Schweitzer, C. M., Gan, J., & DeCaprio, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4465 · Cited by 279
Control of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 279
G. Dunphy, W. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90142-2 · Cited by 276
Wee1 kinase as a target for cancer therapy
Do, K., Doroshow, J. H., & Kummar, S. (2013) · Cell Cycle · doi:10.4161/cc.26062 · Cited by 273
Na-H Exchange-dependent Increase in Intracellular pH Times G2/M Entry and Transition
Putney, L. K., & Barber, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308099200 · Cited by 269
Leijen, S., van Geel, R. M. J. M., Pavlick, A. C., Tibes, R., Rosen, L., Razak, A. R. A., Lam, R., Demuth, T., Rose, S., Lee, M. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5991 · Cited by 264
Ubiquitin Ligases and Cell Cycle Control
Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 252
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
Oza, A. M., Estevez-Diz, M., Grischke, E.-M., Hall, M., Marmé, F., Provencher, D., Uyar, D., Weberpals, J. I., Wenham, R. M., Laing, N., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0219 · Cited by 129
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
Banerjee, N. S., Wang, H.-K., Broker, T. R., & Chow, L. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197574 · Cited by 97
Cell-cycle responses to DNA damage in G2
Cuddihy, A. R., & O'Connell, M. J. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(02)22013-6 · Cited by 89
Zhang, Z., Miao, L., Lv, C., Sun, H., Wei, S., Wang, B., Huang, C., & Jiao, B. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.182 · Cited by 86
Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity
Wright, G., Golubeva, V., Remsing Rix, L. L., Berndt, N., Luo, Y., Ward, G. A., Gray, J. E., Schonbrunn, E., Lawrence, H. R., Monteiro, A. N. A., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00147 · Cited by 77
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Self-citationLi, J., Wu, J., Bao, X., Honea, N., Xie, Y., Kim, S., Sparreboom, A., & Sanai, N. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0983 · Cited by 68
p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775
Hauge, S., Macurek, L., & Syljuåsen, R. G. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593649 · Cited by 30
Fukuda, K., Takeuchi, S., Arai, S., Nanjo, S., Sato, S., Kotani, H., Kita, K., Nishiyama, A., Sakaguchi, H., Ohtsubo, K., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101578 · Cited by 24
Barth, H., Hoffmann, I., Klein‐Scory, S., Kaszkin, M., Richards, J., & Kinzel, V. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199609)168:3<589::aid-jcp11>3.0.co;2-v · Cited by 24
Metadata
- Authors
- Parker, L. L., & Piwnica-Worms, H.
- Venue
- Science
- Published
- 1992-09-25
- Volume
- 257
- Issue
- 5078
- Pages
- 1955-1957
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2038143768
- Cited by
- 716
- References
- 24
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.